Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice

Behavioural Brain Research

Volumn 221, Issue 1, 2011, Pages 75-82

  De Carvalho, Rebeca Santos Marques ^a   Duarte, Filipe Silveira ^a   De Lima, Thereza Christina Monteiro ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

5 HT; Anxiety; Baicalin; Flavonoids; GABA; Sedation

Indexed keywords

BAICALEIN; BENZODIAZEPINE; DIAZEPAM; DIENPAX; FENCLONINE; FLUMAZEN; FLUMAZENIL; PENTETRAZOLE; PRASTERONE SULFATE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG ANTAGONISM; DRUG MECHANISM; FEMALE; GABAERGIC SYSTEM; LOW DRUG DOSE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; SLEEP TIME; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; DEHYDROEPIANDROSTERONE SULFATE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ETHER, ETHYL; FEMALE; FENCLONINE; FLAVANONES; FLUMAZENIL; GABA AGONISTS; GABA ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MAZE LEARNING; MICE; PENTYLENETETRAZOLE; SEIZURES; SLEEP;

EID: 79952988173     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.02.038     Document Type: Article

References (46)

1. Kimura Y., Matsushita N., Okuda H. Effects of baicalein isolated from Scutellaria baicalensis on interleukin 1 beta- and tumor necrosis factor alpha-induced adhesion molecule expression in cultured human umbilical vein endothelial cells. J Ethopharmacol 1997, 57:63-67.
2. Wang H., Hui K.M., Chen Y., Xu S., Wong J.T., Xue H. Structure-activity relationships of flavonoids, isolated from Scutellaria baicalensis, binding to benzodiazepine site of GABA(A) receptor complex. Planta Med 2002, 68(12):1059-1062.
3. Bochorakova H., Paulova H., Slanina J., Musil P., Taborska E. Main flavonoids in the root of Scutellaria baicalensis cultivated in Europe and their comparative antiradical properties. Phytother Res 2003, 17(6):640-644.
4. Heo H.J., Kim D.O., Choi S.J., Shin D.H., Lee C.Y. Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J Agric Food Chem 2004, 52(13):4128-4132.
5. Chen Y.-C., Shen S.-C., Chen L.-G., Lee T.J.-F., Yang L.-L. Wogonin, baicalin and baicalein inhibition of nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 2001, 61:1417-1427.
6. Huang Y., Wong C.M., Lau C.-W., Yao X., Tsang S.Y., Su Y.L., et al. Inhibition of nitric oxide/cyclic GMP-mediated relaxation by purified flavonoids, baicalin and baicalein, in rat aortic rings. Biochem Pharmacol 2004, 67:787-794.
7. Chang W.S., Lee Y.J., Lu F.J., Chiang H.C. Inhibitory effects of flavonoids on xanthine. Anticancer Res 1993, 13(6A):2165-2170.
8. Kyo R., Nakahata N., Sakakibara I., Kubo M., Ohizumi Y. Baicalin and baicalein, constituents of an important medicinal plant, inhibit intracellular Ca2+ elevation by reducing phospholipase C activity in C6 rat glioma cells. J Pharm Pharmacol 1998, 50(10):1179-1182.
9. Liao J.F., Hung W.Y., Chen C.F. Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. Eur J Pharmacol 2003, 464:141-146.
10. Wang S.-Y., Wang H.-H., Chi C.-W., Chieh C.-F., Liao J.F. Effects of baicalein on β-amyloid peptide-(25-35)-induced amnesia in mice. Eur J Pharmacol 2004, 506:55-61.
11. Cheng Y., He G., Mu X., Zhang T., Li X., Hu J., et al. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett 2008, 441:16-20.
12. Mu X., He G., Cheng Y., Li X., Xu B., Du G. Baicalein exerts neuroprotective effects in 6- hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav 2009, 92:642-648.
13. Wang F., Zhiwen X., Ren L., Tsang S.Y., Xue H. GABAA receptor subtype selectivity underlying selective anxiolytic effect of baicalin. Neuropharmacology 2008, 55:1231-1237.
14. Xu Z., Wang F., Tsang S.Y., Ho K.H., Zheng H., Yuen C.T., et al. Anxiolytic-like effect of baicalin and its additivity with other anxiolytic. Planta Med 2006, 72(2):189-192.
15. Zhang L., Lin G., Kovács B., Jani M., Krajcsi P., Zuo Z. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci 2007, 31:221-231.
16. Tarragó T., Kichik N., Claasen B., Prades R., Teixidó M., Giralt E. Baicalin, a prodrug able to reach the CNS, is a prolyloligopeptidase inhibitor. Bioorg Med Chem 2008, 16:7516-7524.
17. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology 1996, 125:65-75.
18. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 1986, 16(4):355-357.
19. Duarte F.S., Marder M., Hoeller A.A., Duzzioni M., Mendes B.G., Pizzolatti M.G., et al. Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites. Psychopharmacology 2008, 97:351-360.
20. Ribeiro S.J., De Lima T.C.M. Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice. Neurosci Lett 1998, 258:155-158.
21. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., Chopde C.T. Evaluation of GABAergic neuroactive steroid 3α-hydroxy-5α-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 2005, 180:267-278.
22. MacDonald R.L., Olsen R.W. GABAA receptor channels. Annu Rev Neurosci 1994, 17:569-602.
23. Duarte F.S., Lach G., Martins P.R.C., Romeiro G.A., De Lima T.C.M. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test. Prog Neuro-Psychopharmacol Biol Psychiatry 2008, 32:368-374.
24. Gavioli E.C., Duarte F.S., Guerrini R., Calo G., Rae G.A., De Lima T.C.M. GABAA signalling is involved in N/OFQ anxiolytic-like effects but not in nocistatin anxiogenic-like action as evaluated in the mouse elevated plus maze. Peptides 2008, 29:1404-1412.
25. Vieira RA, 2001. Avaliação dos efeitos centrais do extrato aquoso (EA) de Stachytarpheta cayennensis Vahl. M.Sc. Dissertation in Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil.
26. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
27. Rodgers R.J., Cole J.C. The elevated pluz-maze: pharmacology, methodology and ethology. Ethology and psychopharmacology 1994, 9-44. Wiley, Chichester. S.J. Cooper, C.A. Hendrie (Eds.).
28. Phillips D.S. Choosing a statistic. Basic statistics for health sciene students 1978, 128-130. W.H. Freeman and Company, San Francisco. J. Freedman, G. Lindzey, R.F. Thompson (Eds.).
29. Calabrese E.J., Baldwin L.A., Holland C.D. Hormesis: a highly generalizable and reproducible phenomenon with important implications for risk assessment. Risk Anal 1999, 19(2):261-281.
30. Wang D.S., Lu S.Y., Hong Z., Zhu H.L. Biphasic action of midazolam on GABAA receptor-mediated responses in rat sacral dorsal commissural neurons. Biochem Biophys Res Commun 2003, 309(4):893-899.
31. Möhler H., Fritschy J.M., Crestani F., Hensch T., Rudolph U. Specific GABAA circuits in brain development and therapy. Biochem Pharmacol 2004, 68:1685-1690.
32. Viola H., Wasowski C., Levi de Stein M., Wolfman C., Silveira R., Dajas F., et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 1995, 61(3):213-216.
33. Wolfman C., Viola H., Paladini A., Dajas F., Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 1994, 47(1):1-4.
34. Fernández S.P., Wasowski C., Paladini A.C., Marder M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur J Pharmacol 2005, 512:189-198.
35. Zanoli P., Avallone R., Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia 2000, 71:117-123.
36. Setem J., Pinheiro A.P., Motta V.A., Morato S., Cruz A.P.M. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacol Biochem Behav 1999, 62(3):515-521.
37. Belelli D., Lambert J.J. Neurosteroids: endogenous regulators of the GABAA receptor. Nat Rev Neurosci 2005, 6:565-575.
38. Liao J.F., Wang H.H., Chen M.C., Chen C.C., Chen C.F. Benzodiazepine binding site-interactive flavones from Scutellaria baicalensis root. Planta Med 1998, 64(6):571-572.
39. Souza A., Ticku M.K. Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site. J Pharmacol Exp Ther 1997, 282:827-833.
40. Fernández S.P., Mewett K.N., Hanrahan J.R., Chebib M., Johnston G.A.R. Flavan-3-ol derivatives are positive modulators of GABAA receptors with higher efficacy for α2 subtype and anxiolytic action in mice. Neuropharmacology 2008, 55(5):900-907.
41. Yu H.-S., Lee S.-Y., Jang C.-G. Involvement of 5-HT1A and GABAA receptors in the anxiolytic-like effects of Cinnamomum cassia in mice. Pharmacol Biochem Behav 2007, 87:164-170.
42. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 1997, 21(6):801-810.
43. Jain N.S., Hirani K., Chopde C.T. Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats. Neuropharmacology 2005, 48:627-638.
44. Carlini E.A., Contar J.D.P., Silva-Filho A.R., Da Silveira-Filho N.G., Frochtengarten M.L., Bueno O.F.A. Pharmacology of lemongrass (Cymbopogon citratus Stapf) I. Effects of teas prepared from the leaves on the laboratory animals. J Ethnopharmacol 1986, 17:37-64.
45. Dalvi A., Rodgers R.J. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacol Biochem Behav 1999, 62(4):727-734.
46. Soderpalm B., Svensson L., Hulthe P., Johannessen K., Engel J.A. Evidence for a role for dopamine in the diazepam locomotor stimulating effect. Psychopharmacology 1991, 104(1):97-102.